title: 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
authors.forename: Glenn N
authors.initials: GN
authors.lastname: Levine
authors.forename: Eric R
authors.initials: ER
authors.lastname: Bates
authors.forename: John A
authors.initials: JA
authors.lastname: Bittl
authors.forename: Ralph G
authors.initials: RG
authors.lastname: Brindis
authors.forename: Stephan D
authors.initials: SD
authors.lastname: Fihn
authors.forename: Lee A
authors.initials: LA
authors.lastname: Fleisher
authors.forename: Christopher B
authors.initials: CB
authors.lastname: Granger
authors.forename: Richard A
authors.initials: RA
authors.lastname: Lange
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Mack
authors.forename: Laura
authors.initials: L
authors.lastname: Mauri
authors.forename: Roxana
authors.initials: R
authors.lastname: Mehran
authors.forename: Debabrata
authors.initials: D
authors.lastname: Mukherjee
authors.forename: L Kristin
authors.initials: LK
authors.lastname: Newby
authors.forename: Patrick T
authors.initials: PT
authors.lastname: O'Gara
authors.forename: Marc S
authors.initials: MS
authors.lastname: Sabatine
authors.forename: Peter K
authors.initials: PK
authors.lastname: Smith
authors.forename: Sidney C
authors.initials: SC
authors.lastname: Smith
mesh_terms: D000465:Algorithms; D001241:Aspirin / Q000008:administration & dosage*; D003324:Coronary Artery Disease / Q000601:surgery*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D058921:Purinergic P2Y Receptor Antagonists / Q000008:administration & dosage*; D013997:Time Factors
chemical_list: D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists; D001241:Aspirin
keywords: ACC/AHA Clinical Practice Guideline; P2Y(12) inhibitor; acute coronary syndrome; aspirin; coronary artery disease; coronary stents; dual antiplatelet therapy (DAPT); focused update; stable ischemic heart disease